2024

• - September 13-17 . ESMO Congress Barcelona
• - June 3-6 BIO . San Diego (USA)
• - May 31–June 4. ASCO Chicago (USA)
• - May 31. Oncology Innovation Forum Chicago - Sachs Forum
• - May 15. AseBio Investor Day. Donostia/ San Sebastián
• - May 12-14. Bio Equity Europe. San Sebastián

2023

• - November 6-8. Bio Europe. Munich, Germany
• - October 24-26. CPhI Barcelona
• - September 26-28. BIO Spain Barcelona
• - June 2-6. 2023 ASCO Annual Meeting. Chicago.
• - May 16-18. BIOMED Israel. The 21st National Life Sciece & Technology Week. Tel Aviv.

2022

• - November - LSX Investival showcase. London
• - October - SACHS Forum. Digital.
• - June - BIO 2022. San Diego. In person
• - April - ASEBIO Investors Day. In person
• - March - BioEurope Spring. Digital.
• - March - Biomed Event. Paris.
• - February - SACHS Forum. Digital.

2021

• September - BioSpain. Pamplona
• May - Anglonordic. Digital
• May - BioEquity. Digital
• March - BIO-Europe Spring. Digital
• February - LSX World Congress. Digital

2020

• March - BIO-Europe Spring. Paris (France)
• February - 15th Biomarkers Series UK. Manchester (United Kingdom) - Marc Yeste, PhD: Pharmacodynamic biomarkers associated to ABTL0812, a phase 2 clinical stage pro-autophagy anticancer drug
• January - J. P. Morgan (USA)

2019

• November - BIO-Europe. Hamburg (Germany)
• September - ESMO: European Society for Medical Oncology. Barcelona
• June - BIO International. Philadelphia (USA)
• June - ASCO Annual Meeting. Chicago (USA)
• May - MIXiii-Biomed 2019. Tel Aviv (Israel)
• January - Invest Securities BioMed Event
• January - 2019 Cholangiocarcinoma Foundation Annual Conference. Salt Lake City (USA)

2018

• October - Pau Muñoz will defend the Doctoral thesis: "Mechanism of action of the new antitumour drug ABTL0812: Role of pseudoquinase TRIB3, reticular stress and sphingolipids in death mediated by autophagy". UAB (Bellaterra, Barcelona)
• October - Sachs Forum. Basel (Switzerland)
• September - BioSpain. Sevilla (Spain)
• June - ASCO Annual Meeting. Chicago, IL (USA)
• June - II Biennal Congress of the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Rome (Italy)
• May - Bio€quity Europe. Ghent (Belgum)

2017

• November - BioEurope. Berlin (Germany)
• October - CPhI Worldwide. Frankfurt (Germany)
• September - ASEBIO Investors Day. Barcelona (Catalnoia)
• September - Sachs Forum. Basel (Switzerland)
• June - 2017 BIO International Convention. San Diego, CA (USA)
• June - ASCO Annual Meeting. Chicago, IL (USA)
• March - BioEurope. Barcelona (Catalonia - Spain)
• March - 10th Annual European Life Sciences CEO Forum & Exhibition. Zurich (Switzerland)

2016

• October - BioEurope. Cologne (Germany)
• October - CPhI. Barcelona (Catalonia, Spain)
• June - BIO international convention. San Francisco, CA (USA)
• September - BioSpain. Bilbao (Spain)
• September - BioJapan (Japan)

2015

• November - AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA (USA)
• September - ESMO: European Society for Medical Oncology. Vienna (Austria)
• May - IATI Biomed. Tel Aviv (Israel)
• May - Biotrinity. London (UK)
• April - Anglonordic Life Science Conference. (Spain)
• February - BIO CEO & Investor Conference. New York, NY (USA)

2013

• April - BIO International Convention. Chicago, IL (USA)
• March - BioEurope Spring. Barcelona (Catalonia, Spain)
• March - Company presentation at 6th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)
• January - Company presentation at Biotech Showcase at JP Morgan Healthcare Conference. San Francisco, CA (USA)

2012

• September - Poster session at the 8th International Translational Oncology Symposium. Barcelona
• July - Poster session at the meeting of the European Association for Cancer Research (EACR). Barcelona (Catalonia, Spain)
• June - Booth at BIO International Convention. Boston, MA (USA)
• June - Company presentation at the International Cancer Cluster Showcase. Boston, MA (USA)
• April - Poster session at the meeting of the American Association for Cancer Research (AACR). Chicago, IL (USA)
• March - Company presentation at 5th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)

2011

• November - Company presentation at NYC Landmark Venture Forum - Investing for Cures. New York, NY (USA)
• November - Company presentation at Foro Neotec (CDTI). Logrono (Spain)
• September - Company presentation at MassBio’s Global Gateway. Boston, MA (USA)
• September - Company presentation at BioPharm America. Boston, MA (USA)
• May - Company presentation at Oncology Forum Farmaindustria. Madrid (Spain)
• June - BIO International Convention. Washington, DC (USA)
• May - 7th International Translational Oncology Symposium. Barcelona (Catalonia, Spain)
• April - BioTrinity. Newbury (United Kingdom)
• January - Company presentation at 4th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)

2010

• November - BioEurope. Munich (Germany)
• November - Company presentation at European Venture Capital Contest Summit. Düsseldorf (Germany)
• October - Company presentation at European Venture Capital Contest Semi-Final. Pamplona (Spain)
• September - Company presentation at BioSpain. Pamplona (Spain)
• August - Company presentation at European Venture Capital Contest Semi-Final. Aarhus (Denmark)
• June - HiT Barcelona World Innovation Summit. Barcelona (Catalonia, Spain)
• March - BioEurope Spring. Barcelona (Catalonia, Spain)